| Literature DB >> 26307210 |
Leonard Anang Sowah1, Ulrike K Buchwald2, David J Riedel2, Bruce L Gilliam2, Mariam Khambaty2, Lori Fantry2, Derek E Spencer2, Jeffery Weaver2, Gregory Taylor3, Mary Skoglund2, Anthony Amoroso2, Robert R Redfield2.
Abstract
In this article, we sought to understand the perceptions and practice of providers on anal cancer screening in HIV-infected patients. Providers in an academic outpatient HIV practice were surveyed. Data were analyzed to determine the acceptability and perceptions of providers on anal Papanicolaou tests. Survey response rate was 55.3% (60.7% among male and 47.4% among female providers). One-third of the providers had received screening requests from patients. Female providers had higher self-rated comfort with anal Papanicolaou tests, with a mean score of 7.1 (95% confidence interval [CI] 4.7-9.5) compared to 3.6 (95% CI 1.5-5.7) for male providers, P = .02. Sixty-seven percent of male providers and 37.5% of female providers would like to refer their patients for screening rather than perform the test themselves. Only 54.2% of our providers have ever performed anal cytology examination. Our survey revealed that not all providers were comfortable performing anal cancer screening for their patients.Entities:
Keywords: MSM; anal cancer; anal cytology; cancer prevention; screening
Mesh:
Year: 2015 PMID: 26307210 DOI: 10.1177/2325957415601504
Source DB: PubMed Journal: J Int Assoc Provid AIDS Care ISSN: 2325-9574